Corporate Business Development - QIAGEN

Commercial opportunities

To continue to meet and exceed customer expectations in our developing commercial markets, QIAGEN plans to optimize and diversify its technology interests in the following areas:

  • Novel technologies for handling and preparing samples prior to analysis of nucleic acids and proteins
  • Fractionation, enrichment, and depletion technologies
  • Amplification technologies
  • Storage, retrieval, and transportation solutions
  • Molecular testing, clinical research, and diagnostics using nucleic acids
  • RNAi synthesis, design, modification, and delivery
  • Gene expression at the RNA and protein level
  • General molecular biology research
Business and technology development
If you know of any product/service development opportunities in the above fields, we would be very interested in hearing from you.
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm